Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
57.56
+5.56 (10.69%)
At close: May 21, 2026

SHA:688192 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
223.7291.42250.1674.2121.67364.24
Trading Asset Securities
1,7111,645589.836741,2951,711
Cash & Short-Term Investments
1,9341,936839.99748.21,4162,075
Cash Growth
115.21%130.51%12.27%-47.18%-31.74%246.26%
Accounts Receivable
170.99143.4427.4948.04-7.55
Other Receivables
3.37-----
Receivables
174.36143.4427.4948.04-7.55
Inventory
32.1436.9544.1123.475.07-
Other Current Assets
65.666.0387.3790.6551.6429.57
Total Current Assets
2,2062,183998.97910.361,4732,112
Property, Plant & Equipment
375.72381.23243.91102.26103.66104.48
Other Intangible Assets
388.16396.43429.85461.98492.02474.9
Long-Term Deferred Charges
3.274.098.6216.997.994.54
Other Long-Term Assets
39.5438.0937.384.795.0649.51
Total Assets
3,0133,0031,7191,4962,0822,746
Accounts Payable
157.7134.8220.3918.578.811.65
Accrued Expenses
47.29331.8245.07182.18208.53182.75
Short-Term Debt
108.95217.45373.83200.11--
Current Portion of Long-Term Debt
351.78291.9741.270.1--
Current Portion of Leases
-21.223.5322.9521.3416.84
Current Income Taxes Payable
24.251.34-0.050-
Current Unearned Revenue
6.855.52.930.98--
Other Current Liabilities
85.5281.1478.0623.499.8210.76
Total Current Liabilities
782.36985.23785.08448.44248.49211.99
Long-Term Debt
966.14688.15683.76138.31--
Long-Term Leases
19.2521.9834.9948.8963.9370.92
Long-Term Unearned Revenue
10.0911.4814.8412.1111-
Total Liabilities
1,7781,7071,519647.75323.43282.91
Common Stock
464.63461.19417.65408.15407.16404.18
Additional Paid-In Capital
4,9894,9563,1362,9542,7572,729
Retained Earnings
-4,219-4,124-3,360-2,514-1,406-669.85
Total Common Equity
1,2341,294193.76848.631,7582,463
Minority Interest
0.691.836.3---
Shareholders' Equity
1,2351,296200.06848.631,7582,463
Total Liabilities & Equity
3,0133,0031,7191,4962,0822,746
Total Debt
1,4461,2411,157410.3785.2787.76
Net Cash (Debt)
488.11695.51-317.39337.831,3311,987
Net Cash Growth
----74.62%-33.02%231.62%
Net Cash Per Share
1.071.56-0.770.833.295.52
Filing Date Shares Outstanding
455.04461.19417.65408.15407.16404.18
Total Common Shares Outstanding
455.04461.19417.65408.15407.16404.18
Working Capital
1,4241,197213.89461.931,2251,900
Book Value Per Share
2.712.810.462.084.326.09
Tangible Book Value
846.33897.43-236.09386.651,2661,988
Tangible Book Value Per Share
1.861.95-0.570.953.114.92
Buildings
-227.2----
Machinery
-160.6755.4349.1431.9926.91
Construction In Progress
--169.7213.358.855.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.